223 related articles for article (PubMed ID: 4591169)
1. Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker.
O'Toole C; Stejskal V; Perlmann P; Karlsson M
J Exp Med; 1974 Mar; 139(3):457-66. PubMed ID: 4591169
[TBL] [Abstract][Full Text] [Related]
2. A 51chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma.
O'Toole C
Int J Cancer; 1977 Mar; 19(3):324-31. PubMed ID: 844912
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity studies in bladder and renal cell cancer.
Elhilali MM; Nayak SK
Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture.
Pape GR; Troye M; Perlmann P
J Immunol; 1977 Jun; 118(6):1925-30. PubMed ID: 325130
[No Abstract] [Full Text] [Related]
5. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
Vilien M
Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
[No Abstract] [Full Text] [Related]
6. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary.
Perlmann P; Troye M; Pape G; Blomgren H; Johansson B
Urol Res; 1978; 6(4):207-9. PubMed ID: 741533
[TBL] [Abstract][Full Text] [Related]
7. K cell mediated lysis of cultured colon carcinoma and urinary bladder carcinoma cells induced by monospecific antisera against carcinoembryonic antigen (CEA) and two CEA-related normal glycoproteins.
Hammarström S; Troye M; Wahlund G; Svenberg T; Perlmann P
Int J Cancer; 1977 Jun; 19(6):756-66. PubMed ID: 873641
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
[TBL] [Abstract][Full Text] [Related]
9. Immunologic evaluation of human bladder cancer: in vitro studies.
Elhilali MM; Nayak SK
Cancer; 1975 Feb; 35(2):419-31. PubMed ID: 1111918
[TBL] [Abstract][Full Text] [Related]
10. Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract.
Hakala TR; Lange PH
Science; 1974 May; 184(4138):795-7. PubMed ID: 4856602
[TBL] [Abstract][Full Text] [Related]
11. Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay.
Troye M; Perlmann P; Larsson A; Blomgren H; Johansson B
Int J Cancer; 1977 Aug; 20(2):188-98. PubMed ID: 892930
[No Abstract] [Full Text] [Related]
12. Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?
O'Toole C; Perlmann P; Wigzell H; Unsgaard B; Zetterlund CG
Lancet; 1973 May; 1(7812):1085-8. PubMed ID: 4123535
[No Abstract] [Full Text] [Related]
13. Cell-mediated cytotoxicity against human bladder cancer.
Bloom ET; Ossorio RC; Brosman SA
Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
[No Abstract] [Full Text] [Related]
14. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera.
Schneider MU; Troye M; Paulie S; Perlmann P
Int J Cancer; 1980 Aug; 26(2):185-92. PubMed ID: 7203712
[TBL] [Abstract][Full Text] [Related]
15. Identification of complement-receptor lymphocytes (B cells) in lymph nodes and tumor infiltrates.
Catalona WJ; Mann R; Nime F; Potvin C; Harty JI; Gomolka D; Eggleston JC
J Urol; 1975 Dec; 114(6):915-21. PubMed ID: 1081603
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.
BubenÃk J
Int Urol Nephrol; 1975; 7(4):297-302. PubMed ID: 1107249
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
Troye M; Vilien M; Pape GR; Perlmann P
Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
[TBL] [Abstract][Full Text] [Related]
18. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
Surg Forum; 1975; 26():122-4. PubMed ID: 56048
[No Abstract] [Full Text] [Related]
19. HLA antigen expression on urothelial cells: detection by antibody-dependent cell-mediated cytotoxicity.
O'Toole CM; Tiptaft RC; Stevens A
Int J Cancer; 1982 Apr; 29(4):391-5. PubMed ID: 7085129
[TBL] [Abstract][Full Text] [Related]
20. Changes in cell-mediated cytotoxicity during the clinical course of patients with bladder carcinoma.
Hakala TR; Lange PH; Elliott AY; Fraley EE
J Urol; 1976 Mar; 115(3):268-73. PubMed ID: 768528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
